Recognizing the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva has opened its expanded Shanghai facility. The facility is 11 000 m2, fully operational, and designed to help advance and accelerate the development of novel therapeutics. Customers have access to a wide range of technologies, solutions, and services, including Cytiva’s Fast Trak training center, a Center of Excellence for single-use technologies, and a new automation and digital lab. It is also home to China’s online experience center, customized bioprocess solutions labs and compliance validation labs.

For those international medical device companies aiming to localize in China, what exactly does "manufactured within China" mean? To what extent does "localization" qualify as "manufactured within China"?

On June 29, Merck announced an investment of approximately 70 million euros to expand its Nantong Life Science Center in the heart of the Yangtze River Delta region.

On June 9, a launching ceremony was held for the Stago Medical Device Factory. On the same day, the opening ceremony of DiaSorin’s Baoshan factory was held.

Recently, the General Office of the State Council communicated Measures of Ministry of Commerce and the Ministry of Science and technology (MOST) for Further Encouraging Foreign Investment in Establishing Research and Development (R&D) Centers in China.

On March 14, 2023, Agilent Technologies announced the establishment of an innovation collaboration lab with Alta Scientific Co., Ltd.

On 13 March, BioMérieux China signed a strategic cooperation agreement with Accunome Biotechnology Co., Ltd.